These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30457869)

  • 1. Selective Inhibitors of Human Neuraminidase 1 (NEU1).
    Guo T; Héon-Roberts R; Zou C; Zheng R; Pshezhetsky AV; Cairo CW
    J Med Chem; 2018 Dec; 61(24):11261-11279. PubMed ID: 30457869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Effect of Neuraminidase-1-Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis.
    Luzina IG; Lillehoj EP; Lockatell V; Hyun SW; Lugkey KN; Imamura A; Ishida H; Cairo CW; Atamas SP; Goldblum SE
    J Pharmacol Exp Ther; 2021 Jan; 376(1):136-146. PubMed ID: 33139318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Inhibitors of Human Neuraminidase 3.
    Guo T; Dätwyler P; Demina E; Richards MR; Ge P; Zou C; Zheng R; Fougerat A; Pshezhetsky AV; Ernst B; Cairo CW
    J Med Chem; 2018 Mar; 61(5):1990-2008. PubMed ID: 29425031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues.
    Zhang Y; Albohy A; Zou Y; Smutova V; Pshezhetsky AV; Cairo CW
    J Med Chem; 2013 Apr; 56(7):2948-58. PubMed ID: 23530623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.
    Hyun SW; Liu A; Liu Z; Cross AS; Verceles AC; Magesh S; Kommagalla Y; Kona C; Ando H; Luzina IG; Atamas SP; Piepenbrink KH; Sundberg EJ; Guang W; Ishida H; Lillehoj EP; Goldblum SE
    Glycobiology; 2016 Aug; 26(8):834-49. PubMed ID: 27226251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioisosteres at C9 of 2-Deoxy-2,3-didehydro-
    Radwan M; Guo T; Carvajal EG; Bekkema BAR; Cairo CW
    J Med Chem; 2024 Aug; 67(16):13594-13603. PubMed ID: 39101748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
    Magesh S; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
    Bioorg Med Chem Lett; 2008 Jan; 18(2):532-7. PubMed ID: 18068975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU4.
    Albohy A; Zhang Y; Smutova V; Pshezhetsky AV; Cairo CW
    ACS Med Chem Lett; 2013 Jun; 4(6):532-7. PubMed ID: 24900705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics simulations of viral neuraminidase inhibitors with the human neuraminidase enzymes: Insights into isoenzyme selectivity.
    Richards MR; Guo T; Hunter CD; Cairo CW
    Bioorg Med Chem; 2018 Oct; 26(19):5349-5358. PubMed ID: 29903413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2.
    Khedri Z; Li Y; Cao H; Qu J; Yu H; Muthana MM; Chen X
    Org Biomol Chem; 2012 Aug; 10(30):6112-20. PubMed ID: 22641268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors.
    Magesh S; Suzuki T; Miyagi T; Ishida H; Kiso M
    J Mol Graph Model; 2006 Oct; 25(2):196-207. PubMed ID: 16427342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-N-acetyl-neuraminic acid.
    Zou Y; Albohy A; Sandbhor M; Cairo CW
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7529-33. PubMed ID: 21036040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent Inhibitors against Newcastle Disease Virus Hemagglutinin-Neuraminidase.
    Rota P; La Rocca P; Piccoli M; Montefiori M; Cirillo F; Olsen L; Orioli M; Allevi P; Anastasia L
    ChemMedChem; 2018 Feb; 13(3):236-240. PubMed ID: 29231283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases.
    Kai H; Hinou H; Nishimura S
    Bioorg Med Chem; 2012 Apr; 20(8):2739-46. PubMed ID: 22410247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoenzyme-Selective Inhibitors of Human Neuraminidases Reveal Distinct Effects on Cell Migration.
    Howlader MA; Guo T; Chakraberty R; Cairo CW
    ACS Chem Biol; 2020 Jun; 15(6):1328-1339. PubMed ID: 32310634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of inhibitor binding in influenza virus neuraminidase.
    Smith BJ; Colman PM; Von Itzstein M; Danylec B; Varghese JN
    Protein Sci; 2001 Apr; 10(4):689-96. PubMed ID: 11274459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A strategy for neuraminidase inhibitors using mechanism-based labeling information.
    Hinou H; Miyoshi R; Takasu Y; Kai H; Kurogochi M; Arioka S; Gao XD; Miura N; Fujitani N; Omoto S; Yoshinaga T; Fujiwara T; Noshi T; Togame H; Takemoto H; Nishimura S
    Chem Asian J; 2011 Apr; 6(4):1048-56. PubMed ID: 21305698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and -9 activation, cellular signaling and pro-inflammatory responses.
    Abdulkhalek S; Szewczuk MR
    Cell Signal; 2013 Nov; 25(11):2093-105. PubMed ID: 23827939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Neuraminidases: Structures and Stereoselective Inhibitors.
    Bourguet E; Figurska S; Fra Czek MM
    J Med Chem; 2022 Feb; 65(4):3002-3025. PubMed ID: 35170942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Cellulo Crystallization of Human Neuraminidase 1 and Biological Roles of
    Tsukimoto J; Takeuchi Y; Horii Y; Iniwa T; Fukushi Y; Nishioka SI; Itoh K
    ACS Appl Bio Mater; 2022 Jan; 5(1):205-213. PubMed ID: 35014832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.